Sunlight and Vitamin D's Role in COVID-19 Prevention and Treatment

Abstract

This paper reviews the evidence for the role of sunlight and vitamin D in modulating immune response to SARS-CoV-2 and other respiratory viruses. Vitamin D, synthesized in the skin upon sunlight exposure, is a potent immunomodulator that regulates both innate and adaptive immunity. We synthesize epidemiological data showing higher COVID-19 mortality in populations at higher latitudes and in winter months, experimental evidence on vitamin D's effect on coronavirus replication, and clinical data on the relationship between vitamin D deficiency and COVID-19 severity. Our analysis supports the hypothesis that vitamin D supplementation and outdoor sunlight exposure may be effective tools for reducing COVID-19 morbidity and mortality.

Introduction

The COVID-19 pandemic prompted urgent investigation into environmental and biological factors that modulate disease severity. Among the most compelling hypotheses to emerge early in the pandemic was the role of vitamin D — both because of its known immunological effects and because of striking geographical patterns in COVID-19 outcomes that tracked closely with latitude and seasonal variation in sunlight.

This work compiles and analyses the then-available evidence linking sunlight exposure, vitamin D status, and COVID-19 outcomes, and makes the case for public health messaging around outdoor activity and vitamin D supplementation as low-cost, safe interventions.

Key Findings

• COVID-19 mortality rates were significantly higher at higher latitudes during the early pandemic period.
• Vitamin D deficiency was strongly associated with severe COVID-19 outcomes in multiple cohort studies.
• Vitamin D modulates ACE2 expression and cytokine production relevant to SARS-CoV-2 pathology.
• Sunlight exposure and vitamin D supplementation are proposed as accessible, safe public health interventions.

Cite This Work